Opens in a new tab
Radiant Pharma
11 October, 2026

Radiant Pharmaceuticals Limited Strengthens Global Connections at CPHI Milan 2026

Share

Milan, Italy | 6–8 October 2026

Radiant Pharmaceuticals Limited successfully participated in CPHI Milan 2026, one of the world’s leading pharmaceutical industry events, held from 6–8 October 2026 at Fiera Milano, Italy.

The event brought together pharmaceutical manufacturers, industry leaders, and business professionals from across the globe, creating a valuable platform for networking, knowledge exchange, and exploring new business opportunities.

Throughout the three-day event, the Radiant team engaged with international industry professionals, highlighting the company’s capabilities in Contract Manufacturing and Finished Products. These interactions provided opportunities to explore potential collaborations, strengthen existing business relationships, and identify new avenues for expanding Radiant’s presence in international markets.

Radiant’s participation at CPHI Milan 2026 reflects its continued commitment to pharmaceutical excellence, international collaboration, and sustainable business growth. The event also reinforced the company’s ambition to establish meaningful partnerships and contribute to the evolving needs of the global pharmaceutical industry.

Radiant Pharmaceuticals Limited extends its sincere appreciation to all visitors, business partners, and industry professionals who connected with the team during the event.

Building on the connections established in Milan, Radiant looks forward to developing long-term strategic partnerships and exploring new opportunities in the global pharmaceutical market.

Share
Radiant Pharma
Table of Contents

Milan, Italy | 6–8 October 2026

Radiant Pharmaceuticals Limited successfully participated in CPHI Milan 2026, one of the world’s leading pharmaceutical industry events, held from 6–8 October 2026 at Fiera Milano, Italy.

The event brought together pharmaceutical manufacturers, industry leaders, and business professionals from across the globe, creating a valuable platform for networking, knowledge exchange, and exploring new business opportunities.

Throughout the three-day event, the Radiant team engaged with international industry professionals, highlighting the company’s capabilities in Contract Manufacturing and Finished Products. These interactions provided opportunities to explore potential collaborations, strengthen existing business relationships, and identify new avenues for expanding Radiant’s presence in international markets.

Radiant’s participation at CPHI Milan 2026 reflects its continued commitment to pharmaceutical excellence, international collaboration, and sustainable business growth. The event also reinforced the company’s ambition to establish meaningful partnerships and contribute to the evolving needs of the global pharmaceutical industry.

Radiant Pharmaceuticals Limited extends its sincere appreciation to all visitors, business partners, and industry professionals who connected with the team during the event.

Building on the connections established in Milan, Radiant looks forward to developing long-term strategic partnerships and exploring new opportunities in the global pharmaceutical market.

Table of Contents

Confidentiality Note:

Any information related to the identities of the patient and reporter will be kept confidential unless it is subject to disclose due to regulatory obligation.

AcceptDecline